We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+2.99%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$996K
(+0.84%)
Cap. Flow
+$5.81M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
38.86%
Holding
79
New
17
Increased
26
Reduced
8
Closed
8
Top Buys
| 1 |
Charles River Laboratories
CRL
|
+$3.24M |
| 2 |
Alaska Air
ALK
|
+$2.41M |
| 3 |
Royalty Pharma
RPRX
|
+$2.19M |
| 4 |
Everest Group
EG
|
+$1.97M |
| 5 |
HP
HPQ
|
+$1.75M |
Top Sells
| 1 |
TGB
Trekor Metals
TGB
|
+$9.62M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$5.27M |
| 3 |
Preformed Line Products
PLPC
|
+$5.17M |
| 4 |
CGAU
Centerra Gold
CGAU
|
+$2.87M |
| 5 |
Keurig Dr Pepper
KDP
|
+$2.24M |
Sector Composition
| 1 | Healthcare | 38.22% |
| 2 | Financials | 12.92% |
| 3 | Technology | 11.1% |
| 4 | Industrials | 10% |
| 5 | Consumer Staples | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alico
ALCO
$303M
| $8.25M | 6.9% |
200,000
| – | – |
|
2
Rigel Pharmaceuticals
RIGL
$762M
| $6.35M | 5.31% |
235,000
+10,000
| +4% | +$336K |
|
|
3
Royalty Pharma
RPRX
$25B
| $6M | 5.01% |
125,000
+50,000
| +67% | +$2.19M |
|
4
Radiant Logistics
RLGT
$437M
| $4.58M | 3.83% |
650,000
| – | – |
|
5
inTEST
INTT
$184M
| $4.5M | 3.77% |
330,000
-87,500
| -21% | -$959K |
|
6
BGC Group
BGC
$5.38B
| $4.4M | 3.68% |
450,000
+50,000
| +13% | +$463K |
|
7
Coherus Oncology
CHRS
$222M
| $3.55M | 2.97% |
2,100,000
| – | – |
|
|
8
Charles River Laboratories
CRL
$11B
| $3.02M | 2.52% |
+17,500
| New | +$3.24M |
|
9
MarineMax
HZO
$766M
| $2.98M | 2.49% |
110,000
+10,000
| +10% | +$277K |
|
10
Newmark Group
NMRK
$2.75B
| $2.85M | 2.38% |
190,000
| – | – |
|
11
Park Hotels & Resorts
PK
$2.93B
| $2.63M | 2.2% |
250,000
+25,000
| +11% | +$276K |
|
12
Organon & Co
OGN
$3.54B
| $2.4M | 2% |
400,000
+200,000
| +100% | +$1.5M |
|
13
Viatris
VTRS
$19.4B
| $2.36M | 1.98% |
175,000
-25,000
| -13% | -$350K |
|
14
Republic Bancorp
RBCAA
$1.75B
| $2.26M | 1.89% |
32,000
| – | – |
|
15
ARKO Corp
ARKO
$864M
| $2.08M | 1.74% |
375,000
-25,000
| -6% | -$139K |
|
16
Eledon Pharmaceuticals
ELDN
$310M
| $2M | 1.67% |
650,000
| – | – |
|
|
17
Everest Group
EG
$14.4B
| $1.96M | 1.64% |
+6,000
| New | +$1.97M |
|
18
Atea Pharmaceuticals
AVIR
$389M
| $1.91M | 1.6% |
355,000
| – | – |
|
19
First Financial Corp
THFF
$902M
| $1.9M | 1.59% |
30,000
+7,500
| +33% | +$477K |
|
20
Bristow Group
VTOL
$1.3B
| $1.88M | 1.57% |
40,000
| – | – |
|
|
21
Alaska Air
ALK
$5.34B
| $1.84M | 1.54% |
+50,000
| New | +$2.41M |
|
22
Innospec
IOSP
$2.04B
| $1.75M | 1.47% |
24,000
+4,000
| +20% | +$311K |
|
|
23
HP
HPQ
$21.7B
| $1.73M | 1.45% |
+90,000
| New | +$1.75M |
|
24
Copa Holdings
CPA
$6.02B
| $1.7M | 1.42% |
15,000
+12,500
| +500% | +$1.64M |
|
25
Evolus
EOLS
$392M
| $1.64M | 1.37% |
400,000
+150,000
| +60% | +$727K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM